![Tom Hochuli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Tom Hochuli
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Direttore/Membro del Consiglio | 01/01/2020 | - |
Amministratore Delegato | 01/01/2020 | - | |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Presidente | 30/01/2024 | - |
Storia della carriera di Tom Hochuli
Statistiche
Distribuzione geografica
Germania | 2 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Health Technology |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Health Technology |
- Borsa valori
- Insiders
- Tom Hochuli
- Esperienza